Rubenstein Mark H MD is categorized under Internal Medicine Practitioners in Boca Raton, FL and active since 2011.
Rubenstein Mark H MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Mark Rubenstein at the company’s single location by writing to 1000 Nw 9th Court # 101, Boca Raton, Florida FL 33486 or by phoning (561) 368-4444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rubenstein Mark H MD |
Contact Person: | Mark Rubenstein |
Address: | 1000 Nw 9th Court # 101, Boca Raton, Florida 33486 |
Phone Number: | (561) 368-4444 |
Website Address: | bsbrmd.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2011 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Rubenstein Mark H MD was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Mark Rubenstein for inquiries that concern Rubenstein Mark H MD by calling the company number (561) 368-4444, as your correspondence is most welcome. Additionally, the physical location of the single location of Rubenstein Mark H MD can be found at the coordinates 26.3602,-80.1057 as well as the street address 1000 Nw 9th Court # 101 in Boca Raton, Florida 33486.
For its online presence, you may visit Rubenstein Mark H MD’s website at bsbrmd.com and engage with its social media outlets through on Twitter and on Facebook.